Skip to main content
. 2014 Jun 13;96(4):438–448. doi: 10.1038/clpt.2014.131

Figure 4.

Figure 4

Comparison of the piperacillin and tazobactam exposures in the plasma (left) and ELF (center), as well as the plasma: ELF ratio (right). The dotted lines illustrate the 8:1 ratio of piperacillin to tazobactam in the administered piperacillin 4.0 g/tazobactam 0.5 g preparation. AUC, area under the concentration–time curve; ELF, epithelial lining fluid.